Avoro Capital Advisors LLC Amicus Therapeutics, Inc. Call Options Transaction History

Avoro Capital Advisors LLC

  • $7.33 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2018

May 15, 2018
BUY
$13.76 - $17.12 $11.7 Million - $14.6 Million
850,100 Added 56.67%
2,350,100 $3.76 Million
Q4 2017

Feb 14, 2018
SELL
$12.51 - $16.24 $18.8 Million - $24.4 Million
-1,500,000 Reduced 50.0%
1,500,000 $1.76 Million
Q3 2017

Nov 14, 2017
BUY
$11.74 - $15.78 $35.2 Million - $47.3 Million
3,000,000
3,000,000 $8.4 Million

Others Institutions Holding FOLD

# of Institutions
282
Shares Held
325M
Call Options Held
260K
Put Options Held
261K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $3.22B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email